Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Richardson, D.
Right arrow Articles by Will, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richardson, D.
Right arrow Articles by Will, E. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 2007-2013
© 2000 European Renal Association-European Dialysis and Transplant Association

Intervention thresholds and ceilings can determine the haemoglobin outcome distribution in a haemodialysis population

Donald Richardson, Cherry Bartlett and Eric J. Will

Department of Renal Medicine, St James's University Hospital, Leeds, UK

We have explored the consequences of setting different thresholds and ceilings for erythropoietin dose changes in two randomized controlled studies of renal anaemia management based on an established algorithm.

Study 1. A large (n=236) unselected haemodialysis cohort was randomized to monthly intervention (increased erythropoietin (Epo)) at haemoglobin (Hb) levels falling below either 10.5 g/dl (group A) or 11.5 g/dl (group B) and followed for 6 months. The mean Hb was 0.6 g/dl higher in the 11.5 g/dl threshold group (11.1 g/dl vs 11.7 g/dl) at 6 months (P=0.001++). The Epo dose did not differ between them (median 133 IU/kg/week, Interquartile range (IQR) 86–217 and 140, IQR 74–227 respectively) (P=NS**).

Study 2. A large (n=211) unselected haemodialysis cohort was randomized to a reduction in Epo dose at Hb levels above either 12.0 g/dl (group C) or 13.0 g/dl (group D). The Hb outcome at 8 months differed between group C (mean 11.5 g/dl, SD 1.4) and group D (12.2, SD 2.1) (P=0.03++). The Epo dose did not significantly differ between groups C and D (median 60 IU/kg/week, IQR 32–142 and 71, IQR 38–117 respectively) (P=NS**).

Study 1 showed that an intervention threshold of 11.0 g/dl with a mean Hb outcome of 11.6 g/dl and SD 1.6 g/dl would produce the desired UK Renal Association Standards outcome of 85% Hb >=10.0 g/dl. Study 2 demonstrated that a ceiling of 12.0 g/dl narrowed the range of Hb values (P<0.001##), achieving a SD of 1.37 g/dl, and reduced the number of patients with a Hb >13.0 g/dl from 25 to 12%. This narrowing of the distribution has cost implications for reaching minimum standards in a haemodialysis population. Formal use of threshold and ceiling values for intervention within an anaemia management system enabled the haemodialysis population outcome mean and SD to be literally prescribed.

Keywords: haemodialysis; haemoglobin; intervention; outcome; thresholds

Correspondence and offprint requests to: Dr Donald Richardson, Renal Research Registrar, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NDT PlusHome page
A. L. M. de Francisco, P. Stenvinkel, and S. Vaulont
Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness
NDT Plus, January 1, 2009; 2(suppl_1): i18 - i26.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. S. Brimble and C. M. Clase
Hemoglobin Variability in Dialysis Patients
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2218 - 2220.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. M. West, K. Harris, M. S. Gilthorpe, C. Tolman, and E. J. Will
Functional Data Analysis Applied to a Randomized Controlled Clinical Trial in Hemodialysis Patients Describes the Variability of Patient Responses in the Control of Renal Anemia
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2371 - 2376.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Carrera
Foreword
Nephrol. Dial. Transplant., June 1, 2007; 22(suppl_4): iv1 - iv1.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Barany and H.-J. Muller
Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease
Nephrol. Dial. Transplant., June 1, 2007; 22(suppl_4): iv10 - iv18.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. J. Will, D. Richardson, C. Tolman, and C. Bartlett
Development and exploitation of a clinical decision support system for the management of renal anaemia
Nephrol. Dial. Transplant., June 1, 2007; 22(suppl_4): iv31 - iv36.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Tolman, D. Richardson, C. Bartlett, and E. Will
Structured Conversion from Thrice Weekly to Weekly Erythropoietic Regimens Using a Computerized Decision-Support System: A Randomized Clinical Study
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1463 - 1470.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
E J Will
Aiming at averages
J R Soc Med, January 12, 2001; 94(12): 617 - 619.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.